stockrowMonte Rosa Therapeutics, Inc. (GLUE) vs Pharming Group N.V. Sponsored ADR (PHAR)
- Monte Rosa Therapeutics, Inc. GLUE 10.49 +2.34%
- Pharming Group N.V. Sponsored ADR PHAR 12.32 +0.16%
Monte Rosa Therapeutics, Inc. and Pharming Group N.V. Sponsored ADR are both Biotechnology companies. Monte Rosa Therapeutics, Inc. and Pharming Group N.V. Sponsored ADR are of similar size ($874.5M and $870.6M). Monte Rosa Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Pharming Group N.V. Sponsored ADR trades at 34.2×. Pharming Group N.V. Sponsored ADR grew revenue faster over the last twelve months: 6.76% against −61.3%. Pharming Group N.V. Sponsored ADR has the higher net margin (6.27% vs −186.2%) and the higher return on invested capital (10.1% vs 0.00%). Across the 18 metrics below, Pharming Group N.V. Sponsored ADR leads on 13 and Monte Rosa Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | GLUE | PHAR | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 85.10% | 68.51% |
| Operating margin | (214.46%) | 8.40% | 0.00% |
| Net margin | (186.24%) | 6.27% | 0.00% |
| Free cash flow margin | (247.98%) | 8.92% | 0.00% |
| Return on equity | (35.30%) | 8.73% | (51.96%) |
| Return on assets | (22.63%) | 5.00% | (46.06%) |
| Return on invested capital | 0.00% | 10.07% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack